semaglutide and heart attack Wegovy Approved for Major Disease Prevention Wegovy slashes heart disease risk

Often, a biopsy is done to rule out skin cancer in a patch of actinic keratosis

As a result, CagriSema failed to meet the primary endpoint of demonstrating non-inferiority to tirzepatide, marking a clear competitive win for Lilly's therapy

Tirzepatide targets two hormone receptorsGLP-1 and GIPwhile semaglutide targets only GLP-1, making tirzepatide a dual-action approach that clinical trials have shown may produce greater weight reduction for some patients

Its remarkably specific

She has also reported steadier blood sugar levels, reduced cardiovascular risk and a 30 percent improvement in total cholesterolnoting that some markers are now better than when she was competing

10.1001/jamaneurol.2016.5778 70 LaneD